内镜下第三脑室造瘘术与立体定向桥前池支架置入术治疗中脑导水管狭窄的比较
单中心回顾性研究纳入2013年1月至2024年7月接受内镜下第三脑室造瘘术(ETV)或立体定向桥前池支架置入术(STS)的中脑导水管狭窄患者,STS组50例(平均年龄46岁),ETV组97例(平均年龄36岁)。两种手术均显著改善症状,因感染或出血翻修率(STS 8% vs ETV 4%)及脑积水治疗不足翻修率(STS 4% vs ETV 13%,P=0.09)均无显著差异。结论认为两种术式安全性和有效性相当,术式选择应个体化。
要点
- ETV与STS治疗中脑导水管狭窄的安全性和有效性相当
- STS更多用于肿瘤所致继发性狭窄,ETV更多用于原发性狭窄
- 因感染或出血翻修率及治疗不足翻修率两组无显著差异
核心结论
- 两种手术方式的安全性和有效性相当,术式选择需个体化决定。
研究设计与样本
- 单中心回顾性研究,纳入2013年1月至2024年7月接受ETV或STS的中脑导水管狭窄患者。
- STS组50例,平均年龄46岁;ETV组97例,平均年龄36岁。
主要发现
- 术后最常见症状为头痛(48%)、认知障碍(46%)和步态障碍(48%),两组术后症状均显著改善。
- 桥前池支架组基底动脉尖端至斜坡距离显著小于ETV组(2.8 vs 3.7 mm,P=0.0007)。
- 因感染或出血翻修率STS 8% vs ETV 4%,因脑积水治疗不足翻修率STS 4% vs ETV 13%(P=0.09),均无显著差异。
- 排除新生儿及按病因分层的亚组分析对结果无影响。
关键数值与推荐
- STS组继发性(肿瘤所致)狭窄占66%,ETV组占21%;ETV组原发性狭窄占76%,STS组占26%。
临床怎么用
- 对于中脑导水管狭窄患者,ETV和STS均可作为治疗选择,需结合病因及个体解剖特征决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The standard treatment for noncommunicating hydrocephalus is endoscopic third ventriculostomy (ETV). An alternative procedure is the stereotactic implantation of a shunt catheter through the ventricles into the prepontine cistern, which serves as a stent (STS). This procedure may reduce the risk of stoma occlusion. The aim of this study was to compare the surgical and clinical results of both procedures. METHODS: Patients with aqueductal stenosis treated by either ETV or STS from January 2013 to July 2024 were included in this single-center retrospective study. Patient records were searched for indication, procedural data, complications, and clinical outcomes. In addition, available MR images were analyzed for the Evans index, basilar artery to clivus distance, and ventricular width. The parameters were compared between ETV and STS groups. RESULTS: STS was performed in 50 patients with a mean age of 46 years and ETV in 97 patients with a mean age of 36 years. STS was carried out more frequently in patients with secondary aqueductal stenosis due to a tumor (66% vs 21%), while ETV was conducted more frequently in patients with primary aqueductal stenosis (76% vs 26%). The distance between the basilar tip and clivus was significantly smaller in the STS group (2.8 vs 3.7 mm, p = 0.0007). The most common symptoms before surgery in both groups were headaches (48%), cognitive impairment (46%), and gait disorder (48%). Both procedures resulted in significant improvement of symptoms. There was no significant difference in the number of revision surgical procedures due to infection or bleeding (STS 8% vs ETV 4%) or insufficiency of the hydrocephalus treatment (STS 4% vs ETV 13%, p = 0.09). Subgroup analyses that excluded newborns and stratified results by etiology of aqueductal stenosis had no effect on the results. CONCLUSIONS: The safety and efficacy of both surgical procedures are comparable. The selection of the surgical approach must be made on an individual basis.
引用
- Ueberschaer M, Wirthensohn K, Niedermeyer S, et al. Comparison of endoscopic third ventriculostomy with stereotactic prepontine stenting in patients with aqueductal stenosis. J Neurosurg. 2025. PMID: 40513234. doi:10.3171/2025.2.JNS242984
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。